Urinary Infections

Cipla launches Huena, India's first non-antibiotic drug to fight UTI

Drug firm Cipla on Friday said it has introduced a non-antibiotic treatment for patients suffering from recurrent urinary tract infections. The company has launched Methenamine Hippurate under the brand name HUENA. This marks a significant step forward for the company in its fight against anti-microbial resistance as it becomes the first to introduce such treatment in India, the Mumbai-based drugmaker said in a statement. Urinary tract infections (UTIs) are the second most common reason for antibiotic use in India, with infection cases doubling over the last 30 years. Women are more susceptible to UTIs, which account for 15 per cent of overall antibiotic prescriptions. Methenamine Hippurate offers an effective, non-antibiotic alternative for preventing UTIs by targeting bacteria in the bladder and urinary tract. Studies show it is as effective as long-term, low-dose antibiotic therapy for UTI prevention, with lower costs and no risk of antibiotic resistance. "We believe this ...

Aiims study finds catheter infections in hospital widespread across India

Bloodstream infections acquired during a hospital stay due to the use of a catheter are prevalent across ICUs in India and are often caused by microbes having a high level of antibiotic resistance, according to a study led by the All India Institute of Medical Sciences, New Delhi. Antibiotic resistance -- in which antibiotic drugs are rendered ineffective because disease-causing microbes have become immune to them -- can extend one's hospital stay and treatment costs, adding stress to a public healthcare system. Estimates published in The Lancet Global Health journal show that on average, around nine bloodstream infection events occur every 1,000 days that a central line -- a catheter inserted in a patient's large vein instead of an intravenous line -- was in place in the intensive care units (ICUs) of Indian hospitals. 'Central line-associated bloodstream infections', or CLABSI, are preventable infections -- often acquired from a hospital environment -- and significantly contribute

Air India passenger urinates on fellow traveller on Delhi-Bangkok flight

An Air India passenger allegedly urinated on a fellow traveller during a flight from the national capital to Bangkok on Wednesday, according to sources. Air India, in a statement, said that an incident of "unruly passenger behavior" was reported on its Delhi-Bangkok flight on April 9 and the matter has been reported to the authorities (DGCA). When asked about the incident, Civil Aviation Minister K Rammohan Naidu on Wednesday said the ministry will take note of the incident and speak to the airline. "If there is any wrongdoing, we will take necessary action," Naidu said on the sidelines of an event in the national capital. "Air India confirms that an incident of unruly passenger behaviour was reported to the cabin crew operating flight AI2336, from Delhi to Bangkok, on April 9, 2025," an Air India spokesperson said. The crew followed all laid down procedures, and the matter has been reported to the authorities, it said. In addition to warning the unruly passenger, the airline s

Wockhardt initiates phase-III clinical study of new antibiotic candidate

Pharmaceutical firm Wockhardt Ltd on Tuesday said it has initiated a global Phase III clinical study of its new antibiotic candidate WCK 5222, which will be completed in 18 months

More than 75% of women go through UTIs, says Co-founder of Pee Safe

UTI can lead to many associated health issues if not managed on time

New study reinforces cranberries don't prevent urinary infections

Originally, it was thought that eating or drinking cranberry products increased the acidity of urine and prevented UTIs